Synchronized Care: Strategies to Improve Patient & Healthcare Outcomes in Heart Failure

SYNCHORONIZED CARE: Strategies to Improve Patient & Healthcare Outcomes in Heart Failure

Question Title

* 1. How many other comorbidities does the majority of Medicare Beneficiaries with heart failure also have?

1 - 2

2 - 3

3 - 4

5 of more

Question Title

* 2. Data from Fonarow et al. showed that at the time of discharge 40% of patients with heart failure were:

Improved with no symptoms

Improved(but still symptomatic)

Clinically stable, but no change from admission

Had improved 1 level in the NYHA classification

Question Title

* 3. The 2013 ACC/AHA Guidelines state that_____________ are reasonable to reduce morbidity and mortality as alternatives to angiotensin-converting enzyme(ACE) inhibitors as first-line therapy for patients with Heart Failure with Reduced Ejection Fraction (HFrEF).

Aspirin

If Channel Blocker (or inhibitor)

Angiotensin II Receptor Blockers (ARBs)

Angiotensin-Receptor Neprilysin Inhibitors (ARNIs)

Question Title

* 4. Taylor et al. showed that in African-American patients with advanced heart failure the addition of a fixed dose of isosorbide dinitrate plus hydralazine to standard therapy for heart failure including neurohormonal blockers results in _______.

A 43% decrease in all cause mortality

A6:F6

A 36% decrease in the risk of hospitalization for heart failure

A 44% increase in the risk of hospitalization for heart failure

Question Title

* 5. Please provide your first and last name.
Pre-test questions will not be scored, your name is required solely to confirm completion.

First Name & Last Name